Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2025-12-16 @ 5:26 PM
Study NCT ID:
NCT06454266
Status:
None
Last Update Posted:
2024-07-30 00:00:00
First Post:
2024-05-05 00:00:00
Brief Title:
First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen)
Sponsor:
Ningbo No 1 Hospital
Organization:
Ningbo No. 1 Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Central Nervous System Lymphoma |
Keywords: